Expanded Carrier Screening: How Is It Used? What Are the Ethical Implications?
Impossible d'ajouter des articles
Désolé, nous ne sommes pas en mesure d'ajouter l'article car votre panier est déjà plein.
Veuillez réessayer plus tard
Veuillez réessayer plus tard
Échec de l’élimination de la liste d'envies.
Veuillez réessayer plus tard
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
-
Lu par :
-
De :
À propos de ce contenu audio
This discussion – which originally took place at the PET Annual Conference – is chaired by Sarah Norcross (Director of PET), with contributions from:
⚫ Sara Levene (Consultant Genetic Counsellor and founder of Guided Genetics)
⚫ Professor Jackson Kirkman-Brown (Science Lead at the Birmingham Women's Fertility Centre)
⚫ Dr Heidi Mertes (Chair of Belgium's Federal Commission for Medical and Scientific Research on Embryos In Vitro)
⚫ Professor Cathy Herbrand (Principal Investigator at PRECAS)
PET is grateful to Reproduction in the Age of Genomic Medicine: The Emergence, Commercialisation and Implications of PReconception Expanded CArrier Screening (PRECAS) – a project based at De Montfort University – for supporting this discussion.
PET is also grateful to Jon Nicoll, who created the opening and closing music for its podcast.
Register at https://www.progress.org.uk/events/upcoming-events/ for upcoming PET events.
Vous êtes membre Amazon Prime ?
Bénéficiez automatiquement de 2 livres audio offerts.Bonne écoute !
Aucun commentaire pour le moment